H35.103

Clinical Causes: Premature birth: ROP mainly affects infants born before 31 weeks of gestation. Low birth weight: Infants weighing less than 2.5 pounds (about 1,100 grams) are at higher risk. Oxygen therapy: Excessive oxygen administered during neonatal care can contribute to abnormal blood vessel growth in the retina. Respiratory distress: Conditions requiring oxygen administration can increase ROP risk. Genetic factors: Family history and genetic predisposition may play a role in susceptibility.

Key Symptoms: Redness or swelling around the eye Abnormal eye movements Vitreous haze or floaters Loose or detached retina leading to visual changes In some cases, there are no noticeable symptoms during early stages

Diagnosis Path: Diagnosis of ROP involves a comprehensive eye examination by an ophthalmologist, typically conducted through dilated eye exams. During this assessment, the doctor examines the retina for signs of abnormal blood vessel growth, scarring, or detachment. Additional imaging tests, such as fluorescein angiography, may be used to evaluate blood vessel development and detect areas at risk. Regular screening is vital for premature infants to identify and monitor the condition at various stages of development.

Treatment Protocols: Treatment options depend on the severity and progression of ROP. Common approaches include: - **Laser therapy:** Focused laser treatment helps to ablate the abnormal blood vessels, preventing progression to retinal detachment. - **Cryotherapy:** An older method involving freezing therapy to halt abnormal blood vessel growth. - **Injected medications:** Anti-VEGF (vascular endothelial growth factor) drugs may be used to inhibit abnormal blood vessel growth. - **Monitoring:** Mild cases may require regular observation without immediate intervention. Early detection and timely treatment are crucial for preserving vision, and ongoing follow-up is essential for managing any potential complications.